Cucurbitacin-I and WP1066 administration or shRNA knockdown resulted in on-target JAK2/STAT3 inhibition and dramatically reduced GBM-derived Brain tumor stem cells [17]. The gene discussed is JAK2; the disease is brain neoplasm.